OLIPASS CORPORATION
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
244460 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 동백중앙로16번길 16-4 에이스동백타워1동 20층, 용인시
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
OLIPASS CORPORATION is a biotechnology company focused on the research and development of RNA therapeutics. The company's core technology is its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. This platform utilizes a modified PNA with covalently attached cationic lipid groups, which significantly enhances cell permeability. OPNA is designed to induce exon skipping by specifically binding to target pre-mRNA within the cell nucleus. This mechanism enables the development of a pipeline of novel therapeutic drug candidates for various diseases. The company's vision is to become a leading global R&D company in the field of RNA therapeutics.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for OLIPASS CORPORATION and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-15 00:00 |
Regulatory News Service
[기재정정]투자판단관련주요경영사항 (신약 공동연구개발 연구개발비 수령)
|
Korean | 11.7 KB | |
| 2025-09-15 00:00 |
Regulatory News Service
[기재정정]투자판단관련주요경영사항 (신약 공동연구개발 연구개발비 수령)
|
Korean | 11.3 KB | |
| 2025-09-15 00:00 |
Regulatory News Service
[기재정정]투자판단관련주요경영사항 (신약 공동연구개발 연구개발비 수령)
|
Korean | 10.7 KB | |
| 2025-09-12 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
|
Korean | 16.1 KB | |
| 2025-09-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 63.1 KB | |
| 2025-09-10 00:00 |
Delisting Announcement
기타시장안내 (상장폐지 관련 이의신청서 접수)
|
Korean | 2.9 KB | |
| 2025-09-08 00:00 |
M&A Activity
기타경영사항(자율공시) (공개매각을 위한 주간사계약 체결의 건)
|
Korean | 5.5 KB | |
| 2025-08-20 00:00 |
Delisting Announcement
기타시장안내 (기업심사위원회 개최 결과 안내)
|
Korean | 3.3 KB | |
| 2025-08-20 00:00 |
Delisting Announcement
주권매매거래정지기간변경 (상장폐지 사유 발생)
|
Korean | 5.2 KB | |
| 2025-08-18 00:00 |
Regulatory News Service
불성실공시법인지정 (공시번복 2건)
|
Korean | 7.6 KB | |
| 2025-08-14 00:00 |
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
|
Korean | 12.2 KB | |
| 2025-08-14 00:00 |
Earnings Release
반기또는분기매출액미달사실발생
|
Korean | 5.5 KB | |
| 2025-08-14 00:00 |
Delisting Announcement
기타시장안내 (상장적격성 실질심사 사유추가 안내)
|
Korean | 2.9 KB |
Automate Your Workflow. Get a real-time feed of all OLIPASS CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for OLIPASS CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
